Especially, Cao et al., found the presence of the hybrids (defined by GFAP+ and CD68+ double-positive cells) in clinical GBM samples, and they also demonstrated the formation of the hybrid by co-culturing the murine GL261 GBM cell line with bone marrow-derived macrophages. This evidence concerns the gene GFAP and glioblastoma.